$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Emulsion vehicle for poorly soluble drugs 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A01N-025/00
출원번호 US-0003173 (1998-01-05)
발명자 / 주소
  • Karel J. Lambert
  • Panayiotis P. Constantinides
  • Steven C. Quay
출원인 / 주소
  • Sonus Pharmaceuticals, Inc.
대리인 / 주소
    Christensen O'Connor Johnson Kindness PLLC
인용정보 피인용 횟수 : 110  인용 특허 : 30

초록

An emulsion of .alpha.-tocopherol, stabilized by biocompatible surfactants, as a vehicle or carrier for therapeutic drugs, which is substantially ethanol free and which can be administered to animals or humans various routes is disclosed. Also included in the emulsion is PEGylated vitamin E. PEGylat

대표청구항

1. A pharmaceutical composition, comprising a chemotherapeutic agent, wherein the chemotherapeutic agent is at least one of a taxoid, a taxane, or a taxine; a tocopherol; tocopherol polyethylene glycol succinate; polyethylene glycol; a surfactant; and an aqueous phase; wherein the composition is an

이 특허에 인용된 특허 (30)

  1. Janoff Andrew S. (Yardley PA) Bolcsak Lois E. (Lawrenceville NJ) Weiner Alan L. (Lawrenceville NJ) Tremblay Paul A. (Hamilton NJ) Bergamini Michael V. W. (Easton PA), Alpha tocopherol-based vesicles.
  2. Barnwell Stephen G. (Chester GB2), Biphasic release formations for lipophilic acids.
  3. Desai Narendra R. (Danbury CT) Shinal Edward C. (Old Tappan NJ) Ganesan Madurai (Pomona NY) Carpentier Eugene A. (Spring Valley NY), Emulsion compostions for the parenteral administration of sparingly water soluble ionizable hydrophobic drugs.
  4. Janoff Andrew S. (Yardley PA) Bolcsak Lois E. (Lawrenceville NJ) Weiner Alan L. (Lawrenceville NJ) Tremblay Paul A. (Hamilton NJ) Bergamini Michael V. W. (Cupertino CA) Suddith Robert L. (Robbinsvill, Entrapment of water-insoluble compound in alpha tocopherol-based vesicles.
  5. Trissel Lawrence A. (Houston TX), Extended stability formulations for paclitaxel.
  6. Hausheer Frederick H. ; Haridas Kochat ; Murali Dhanabalan ; Reddy Dasharatha Gauravaram, Formulations and compositions of poorly water soluble camptothecin derivatives.
  7. Story Michael J. (Glenside AUX), Gelatin pharmaceutical formulations.
  8. Greenwald Richard B. (Somerset NJ) Pendri Annapurna (Matawan NJ), High molecular weight polymer-based prodrugs.
  9. Hamann Hans-Jurgen (Dormagen DEX) Serno Peter (Bergisch Gladbach DEX) Herboth Matthias (Leverkusen DEX) Kurka Peter (Hilden DEX), Injectable liposomal pharmaceutical preparations.
  10. Ansell Steve (Vancouver CAX), Lipophilic drug derivatives for use in liposomes.
  11. Barenholz Yechezkel (Jerusalem CA ILX) Gabizon Alberto (San Francisco CA), Liposome/doxorubicin composition and method.
  12. Barenholz Yechezkel (Jerusalem CA ILX) Gabizon Alberto (San Francisco CA), Lipsome/anthraquinone drug composition and method.
  13. Brown Dennis M. (Menlo Park CA) Jones Richard E. (Palo Alto CA) Maskiewicz Richard (Sunnyvale CA) Michaels Shawnya K. (Pacifica CA), Methods and compositions for the treatment of a host with a cellular proliferative disease.
  14. Canetta Renzo M. (Madison CT) Eisenhauer Elizabeth (Kingston CAX) Rozencweig Marcel (Brandford CT), Methods for administration of taxol.
  15. Kawata Hiroitsu (Saitama JPX) Ohmura Tadayoshi (Niiza JPX) Hasumi Shunji (Saitama JPX) Konno Yutaka (Saitama JPX) Aruga Masayoshi (Saitama JPX) Tashiro Seiki (Kumamoto JPX) Konno Toshimitsu (Kumamoto, Oily compositions of antitumor drugs.
  16. Kovacs Istvan (Debrecen HUX) Jusztin Marta (Debrecen HUX) Takacs Erzsebet (Debrecen HUX) Balazs Zoltan (Debrecen HUX) Kiss Ildiko (Ebes HUX) Varga Zsolt (Debrecen HUX) Jancso Sandor (Debrecen HUX) He, Oral pharmaceutical preparation.
  17. Andersson Borje S., Parenteral paclitaxel in a stable non-toxic formulation.
  18. Nyqvist Hkan (Tullinge SEX) Einarsson Monica (Upsala SEX) Mattsson Christer (Kungsbacka SEX), Pharmaceutical composition containing a defined lipid system.
  19. Shively Merrick L. (Louisville CO), Pharmaceutical solutions and emulsions containing taxol.
  20. Agharkar Shreeram N. (Fayetteville NY) Gogate Uday S. (East Syracuse NY), Stabilized pharmaceutical composition and stabilizing solvent.
  21. Wheeler Jeffery J. (Vancouver CAX) Bally Marcel B. (Bowen Island CAX), Stable microemulsions for hydrophobic compound delivery.
  22. Kaufman Robert J. (University City MO) Richard Thomas J. (University City MO) Fuhrhop Ralph W. (St. Louis MO), Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same.
  23. Boni Lawrence (Monmouth Junction NJ) Portnoff Joel (Langhorne PA), Taxane-containing phosphatidylcholine liposomes.
  24. Mass Jean-Pierre (Montpellier FRX), Therapeutic composition containing alpha-linolenic acid and a compound capable of promoting the passage of the acid thro.
  25. Hendler Sheldon S. (La Jolla CA) Sanchez Robert (Carlsbad CA), Tocopherol-based antiviral agents and method of using same.
  26. Peat, Raymond F., Treatment of progesterone deficiency and related conditions with a stable composition of progesterone and tocopherols.
  27. Meybeck Alain (Courbevoie FRX) Bonte Frederic (Courbevoie FRX) Marechal Christian (Paris FRX), Use of a 상세보기
  • Stillman, Theodore, Vitamin E compositions and methods.
  • Wu Stephen H. W. (Kingsport TN) Greene Carol J. (Mt. Carmel TN) Sharma Mahendra K. (Kingsport TN), Water-dispersible polymeric compositions.
  • Desai Neil P. (Los Angeles CA) Soon-Shiong P. (Los Angeles CA) Sandford Paul A. (Los Angeles CA), Water-soluble polymeric carriers for drug delivery.
  • 이 특허를 인용한 특허 (110)

    1. Seo, Min Hyo; Lee, Sa-Won; Hyun, Myung-Han; Yu, Jeong-Il; Chang, Dong-Hoon; Yoon, Hye-Jeong; Kim, Jeong-Kyung, Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery.
    2. Seo,Min Hyo; Kim,Bong Oh; Choi,In Ja; Shim,Myung Seob, Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery.
    3. Kotyla, Timothy, Amphiphilic entity nanoparticles.
    4. Ryan, Robert O.; Oda, Michael N., Bioactive agent delivery particles.
    5. Bosch, H. William; Cooper, Eugene R.; McGurk, Simon L., Bioadhesive nanoparticulate compositions having cationic surface stabilizers.
    6. Patel, Mahesh V.; Chidambaram, Nachiappan; Nachaegari, Satish Kumar; Venkateshwaran, Srinivasan; Frank, Joel, Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters.
    7. Patel, Mahesh V.; Chidambaram, Nachiappan; Nachaegari, Satish Kumar; Venkateshwaran, Srinivasan; Frank, Joel, Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters.
    8. Castillo, Gerardo M.; Bolotin, Elijah, Composition for long-acting peptide analogs.
    9. Castillo, Gerardo M.; Bolotin, Elijah M., Composition for long-acting peptide analogs.
    10. Castillo, Gerardo M.; Bolotin, Elijah M., Composition for long-acting peptide analogs.
    11. Desai, Neil P.; Soon-Shiong, Patrick; Trieu, Vuong, Compositions and methods of delivery of pharmacological agents.
    12. Desai, Neil P.; Soon-Shiong, Patrick; Trieu, Vuong, Compositions and methods of delivery of pharmacological agents.
    13. Desai, Neil P.; Soon-Shiong, Patrick; Trieu, Vuong, Compositions and methods of delivery of pharmacological agents.
    14. Desai, Neil P.; Soon-Shiong, Patrick; Trieu, Vuong, Compositions and methods of delivery of pharmacological agents.
    15. Desai, Neil P.; Soon-Shiong, Patrick; Trieu, Vuong, Compositions and methods of delivery of pharmacological agents.
    16. Desai, Neil P.; Soon-Shiong, Patrick; Trieu, Vuong, Compositions and methods of delivery of pharmacological agents.
    17. Bolotin, Elijah M.; Castillo, Gerardo M., Compositions for delivery of therapeutics and other materials.
    18. Bolotin, Elijah M.; Castillo, Gerardo M., Compositions for delivery of therapeutics and other materials.
    19. Bolotin, Elijah M.; Castillo, Gerardo M., Compositions for delivery of therapeutics and other materials.
    20. Bolotin, Elijah M.; Castillo, Gerardo M., Compositions for delivery of therapeutics and other materials.
    21. Bolotin, Elijah M., Compositions for delivery of therapeutics and other materials, and methods of making and using the same.
    22. Bolotin,Elijah M., Compositions for delivery of therapeutics and other materials, and methods of making and using the same.
    23. Bolotin, Elijah M., Compositions for treatment with glucagon-like peptide, and methods of making and using the same.
    24. Malinin, Vladimir, Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods of use thereof.
    25. Swanson, Jon; Jain, Rajeev A.; Hontz, Robert; Devane, John G.; Cumming, Kenneth Iain; Clancy, Maurice Joseph Anthony; Codd, Janet Elizabeth; Liversidge, Gary, Controlled-release nanoparticulate compositions.
    26. Zhao, Jonathon Z., Device for local and/or regional delivery employing liquid formulations of therapeutic agents.
    27. Zhao, Jonathon Z., Device for local and/or regional delivery employing liquid formulations of therapeutic agents.
    28. Palepu, Nagesh, Docetaxel formulations with lipoic acid.
    29. Palepu, Nagesh, Docetaxel formulations with lipoic acid.
    30. Palepu, Nageswara R., Docetaxel formulations with lipoic acid.
    31. Palepu, Nageswara R., Docetaxel formulations with lipoic acid and/or dihydrolipoic acid.
    32. Dong, Liang-Chang; Espinal, Steven; Wong, Patrick S. L., Dosage form comprising liquid formulation.
    33. Dong,Liang Chang; Espinal,Steven; Wong,Patrick S. L., Dosage form comprising liquid formulation.
    34. Zhao, Jonathon Z., Drug coated expandable devices.
    35. Lambert,Karel J.; Constantinides,Panayiotis P.; Tustian,Alexander K.; Quay,Steven C., Emulsion vehicle for poorly soluble drugs.
    36. Desai, Neil P.; Soon-Shiong, Patrick, Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof.
    37. Desai, Neil P.; Tao, Chunlin; Yang, Andrew; Louie, Leslie; Soon-Shiong, Patrick, Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof.
    38. Bosch, H. William; Ryde, Niels P.; Jain, Rajeev A.; Swanson, Jon; Hontz, Robert; Devane, John G.; Cumming, Kenneth Ian; Clancy, Maurice Joseph Anthony; Codd, Janet Elizabeth; Liversidge, Gary G., Glipizide compositions.
    39. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
    40. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
    41. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
    42. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
    43. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
    44. Giliyar, Chandrashekar; Chickmath, Basawaraj; Nachiappan, Chidambaram; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
    45. Giliyar, Chandrashekar; Chickmath, Basawaraj; Nachiappan, Chidambaram; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
    46. Giliyar, Chandrashekar; Venkateshwaran, Srinivasan; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V, High-strength testosterone undecanoate compositions.
    47. Castillo, Gerardo M.; Bolotin, Elijah M., Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same.
    48. Cooper, Eugene R.; Bullock, John A.; Chippari, John R.; Schaefer, John L.; Patel, Rakesh A.; Jain, Rajeev; Strasters, Joost; Ryde, Niels P.; Ruddy, Stephen B., In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositions.
    49. Cooper, Eugene R.; Bullock, John A.; Chippari, John R.; Schaefer, John L.; Patel, Rakesh A.; Jain, Rajeev; Strasters, Joost; Ryde, Niels P.; Ruddy, Stephen B., In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositions.
    50. Falotico, Robert; Zhao, Jonathon Z., Injectable formulations of taxanes for cad treatment.
    51. Falotico, Robert; Zhao, Jonathon Z., Injectable formulations of taxanes for cad treatment.
    52. Weers, Jeff, Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof.
    53. Weers, Jeff, Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof.
    54. Weers, Jeff, Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof.
    55. Weers, Jeff, Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof.
    56. Weers, Jeff, Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof.
    57. Weers, Jeff, Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof.
    58. Weers, Jeff, Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof.
    59. Weers, Jeff, Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof.
    60. Weers, Jeff, Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof.
    61. Weers, Jeff, Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof.
    62. Ryan, Robert O.; Oda, Michael N., Lipophilic drug delivery vehicle and methods of use thereof.
    63. Ryan, Robert O.; Oda, Michael N., Lipophilic drug delivery vehicle and methods of use thereof.
    64. Ryan, Robert O., Lipophilic nucleic acid delivery vehicle and methods of use thereof.
    65. Chen, Andrew Xian, Low oil emulsion compositions for delivering taxoids and other insoluble drugs.
    66. Gupta, Renu, Method for treating pulmonary disorders with liposomal amikacin formulations.
    67. Gupta, Renu, Method of treating pulmonary disorders with liposomal amikacin formulations.
    68. Gupta, Renu, Method of treating pulmonary disorders with liposomal amikacin formulations.
    69. Wertz, Christian F.; Ryde, Niels P., Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizer.
    70. Alkon, Daniel, Methods for Alzheimer's Disease treatment and cognitive enhancement.
    71. Alkon, Daniel, Methods for Alzheimer's disease treatment and cognitive enhancement.
    72. Etcheberrigaray, Rene; Alkon, Daniel L., Methods for Alzheimer's disease treatment and cognitive enhancement.
    73. Eagle, Gina; Gupta, Renu, Methods for treating pulmonary non-tuberculous mycobacterial infections.
    74. Eagle, Gina; Gupta, Renu, Methods for treating pulmonary non-tuberculous mycobacterial infections.
    75. Eagle, Gina; Gupta, Renu, Methods for treating pulmonary non-tuberculous mycobacterial infections.
    76. Gupta, Renu, Methods of treating pulmonary disorders with liposomal amikacin formulations.
    77. Gupta, Renu, Methods of treating pulmonary disorders with liposomal amikacin formulations.
    78. Gupta, Renu, Methods of treating pulmonary disorders with liposomal amikacin formulations.
    79. Kwon, Glen S.; Forrest, Marcus L., Micelle composition of polymer and passenger drug.
    80. Kwon, Glen S.; Forrest, Marcus L., Micelle composition of polymer and passenger drug.
    81. Wertz, Christian F.; Ryde, Niels P., Nanoparticulate compositions having lysozyme as a surface stabilizer.
    82. Nabeta, Kiichiro, Non-aqueous taxane formulations and methods of using the same.
    83. Nabeta, Kiichiro, Non-aqueous taxane formulations and methods of using the same.
    84. Nabeta, Kiichiro, Non-aqueous taxane nanodispersion formulations and methods of using the same.
    85. Castillo, Gerardo M.; Bolotin, Elijah M.; Bogdanov, Jr., Alexei A., Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same.
    86. Gutierrez-Rocca, Jose C.; Cacace, Janice L.; Selim, Sami; Testman, Robert; Rutledge, J. Michael, Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same.
    87. Ghosh, Swapan K., Phytol derived immunoadjuvants and their use in vaccine formulations.
    88. Ryan, Robert O.; Oda, Michael N., Processes for the preparation of lipophilic drug delivery vehicles.
    89. Bosch, H. William; Ostrander, Kevin D.; Cooper, Eugene R., Propellant-based nanoparticulate dry powder aerosols and method of making.
    90. Alkon, Daniel L., Protein synthesis required for long-term memory is induced by PKC activation on days preceding associative learning.
    91. Dadino, Ronald C.; Zhao, Jonathon Z., Rapamycin coated expandable devices.
    92. Dadino, Ronald C.; Zhao, Jonathon Z., Rapamycin coated expandable devices.
    93. McChesney, James D.; Nikoulin, Igor; Rodenburg, Douglas L., Solubilization of pterostilbene and resveratrol in aqueous beverages.
    94. Otoda, Kazuya; Nakamura, Mayumi; Ariyama, Teruko; Nakagawa, Takashi, Solubilization preparation.
    95. Castillo, Gerardo M.; Bolotin, Elijah, Soluble hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same.
    96. Castillo, Gerardo M.; Bolotin, Elijah M., Soluble hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same.
    97. Perkins, Walter; Malinin, Vladimir, Stabilized vancomycin formulations.
    98. Giliyar, Chandrashekar; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivasan, Steroidal compositions.
    99. Giliyar, Chandrashekar; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivasan, Steroidal compositions.
    100. Boni, Lawrence T.; Miller, Brian S.; Malinin, Vladimir; Li, Xingong, Sustained release of antiinfectives.
    101. Boni, Lawrence T.; Miller, Brian S.; Malinin, Vladimir; Li, Xingong, Sustained release of antiinfectives.
    102. Perkins, Walter; Malinin, Vladimir; Li, Xingong; Miller, Brian; Seidel, Dominique; Holzmann, Philipp; Schulz, Harald; Hahn, Michael, Systems for treating pulmonary infections.
    103. Kiichiro, Nabeta, Taxane pro-emulsion formulations and methods making and using the same.
    104. Zohar, Ofer; Alkon, Daniel L., Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and brain injury.
    105. Zhang, Yuehua; Lal, Manjari; Palepu, Nagesh, Tocopherol derivatives.
    106. Zhang,Yuehua; Gold,Lynn C., Tocopherol-modified therapeutic drug compounds.
    107. Sun, Miao-Kun; Alkon, Daniel L, Treatment of depressive disorders.
    108. Rosenthal, Gary J.; Etter, Jeffrey B.; Rodell, Timothy C.; Schauer, Wren H.; Samaniego, Adrian, Treatment of mucositis.
    109. Troha,Janice Mary; Abbas,Victoria Jean; Rosenthal,Gary Joseph; Schauer,Wren Henderson, Treatment of xerostomia.
    110. Chen, Andrew Xian, Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof.
    섹션별 컨텐츠 바로가기

    AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

    AI-Helper 아이콘
    AI-Helper
    안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
    ※ AI-Helper는 부적절한 답변을 할 수 있습니다.

    선택된 텍스트

    맨위로